Nicotine Patches

PreclinicalSmall molecule

UUniversity of California, San Diego

Nicotine Patches is one of 61 small molecule programs targeting Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CancerCompleted

SmokingCompleted

CancerPreclinical

Completed

SmokingPreclinical

Completed

Competition

Competitive Landscape

57 competitors in Cancer

#DrugCompanyPhaseTrials

Vemlidy

Gilead

Approved

1 2

Lipitor

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

1 3

Tecentriq

Roche

Phase 2

5 4

Keytruda

Merck & Co.

Phase 2

4 5

Afinitor

Novartis

Phase 2

3 6

Cotellic

Roche

Phase 2

3 7

Verzenio

Eli Lilly

Phase 2

2 8

Stivarga

Bayer

Phase 2

2 9

Imfinzi

AstraZeneca

Phase 2

2 10

Erivedge

Roche

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Smoking Cessation11 trials

Smoking Cessation in Hospitalized Smokers

Completed·UUniversity of California, San Diego·Phase 4·NCT01289275·1,270 enrolled

Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging

Completed·UUniversity of California, San Diego·Phase 3·NCT01287377·243 enrolled

Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants

Terminated·—·Phase 2/3·NCT01560507·19 enrolled

Show 8 more trials

Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers

Completed·—·Phase 2·NCT01806779·376 enrolled

Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation

Completed·—·Phase 3·NCT01406223·282 enrolled

Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype

Completed·—·Phase 3·NCT00894166·606 enrolled

Concurrent Bupropion / Varenicline for Smoking Cessation

Completed·—·Phase 3·NCT01303861·702 enrolled

Social Determinants and Smoking Cessation

Completed·MM.D. Anderson Cancer Center··NCT01310842·329 enrolled

Low-Cost Contingency Management for Smoking Cessation

Completed·UUniversity of California, San Francisco·N/A·NCT01040260·103 enrolled

Health Literacy and Smoking Cessation in Low-SES Diverse Smokers - Project HALT II

Withdrawn·MM.D. Anderson Cancer Center·Phase 1·NCT02942212

Clinical Trial to Evaluate the Efficacy of Smoking Cessation

Completed·JJosep Maria Ramon Torrell, PhD·Phase 4·NCT01538394·322 enrolled

Smoking2 trials

Strategies to Help Adult ED Patients Quit Smoking

Completed·NNational Institute on Drug Abuse (NIDA)·N/A·NCT00297466·336 enrolled

Project Quit: Positive vs. Negative Offers of an Online Stop Smoking Program

Completed·UUniversity of Michigan·N/A·NCT01923467·767 enrolled

Randomized2 trials

A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline

Completed·UUniversity of California, San Diego·Phase 3·NCT01502306·3,816 enrolled

A Randomized Trial of Internet Access to Nicotine Patches

Completed·UUniversity of Michigan·N/A·NCT00534404·2,485 enrolled

Cancer1 trial

Reducing Cancer Disparities Among Latinos in Texas

Completed·MM.D. Anderson Cancer Center·N/A·NCT01504919·301 enrolled

Veteran1 trial

Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers

Completed·VVA Office of Research and Development·Phase 4·NCT02245308·133 enrolled

1 more indication

Smokers1 trial

Providing Free Nicotine Patches to Quitline Smokers

Completed·UUniversity of California, San Diego·Phase 3·NCT01736085·3,706 enrolled

Sources

References

[1]
ClinicalTrials.gov — 18 trial records for Nicotine Patches. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Nicotine Patches compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Nicotine Patches. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of California, San Diego company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of California, San Diego

Nicotine Patches

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Smoking Cessation11 trials

Smoking2 trials

Randomized2 trials

Cancer1 trial

Veteran1 trial

Smokers1 trial

References

Drug Info

Quick Facts

Related News